247 related articles for article (PubMed ID: 29361662)
1. Pharmaceuticals and Medical Devices: FDA Oversight.
White RS;
Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-33. PubMed ID: 29361662
[No Abstract] [Full Text] [Related]
2. Pharmaceuticals and Medical Devices: FDA Oversight.
White RS;
Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-42. PubMed ID: 30695853
[No Abstract] [Full Text] [Related]
3. Pharmaceuticals and Medical Devices: FDA Oversight.
Berry MD; White RS;
Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-59. PubMed ID: 28252888
[No Abstract] [Full Text] [Related]
4. Improving the security and privacy of implantable medical devices.
Maisel WH; Kohno T
N Engl J Med; 2010 Apr; 362(13):1164-6. PubMed ID: 20357279
[No Abstract] [Full Text] [Related]
5. Modernizing device regulation.
Garber AM
N Engl J Med; 2010 Apr; 362(13):1161-3. PubMed ID: 20335575
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: medical devices. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217916
[No Abstract] [Full Text] [Related]
7. Pharmaceuticals and Medical Devices: Medical Devices.
Berry MD;
Issue Brief Health Policy Track Serv; 2015 Dec; ():1-64. PubMed ID: 27116798
[No Abstract] [Full Text] [Related]
8. FDA user fee and Modernisation Act.
Donawa M
Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
[TBL] [Abstract][Full Text] [Related]
9. FDA's new regulatory paradigms for in vitro diagnostic devices.
Robinowitz M; Gutman SI
Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
[No Abstract] [Full Text] [Related]
10. Pharmaceuticals and medical devices: medical devices. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
[No Abstract] [Full Text] [Related]
11. In search of a coherent framework: options for FDA oversight of genetic tests.
Javitt GH
Food Drug Law J; 2007; 62(4):617-52. PubMed ID: 18557224
[No Abstract] [Full Text] [Related]
12. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
[No Abstract] [Full Text] [Related]
13. Will new FDA rules hasten device approval?
Hosp Mater Manage; 2003 Jul; 28(7):2, 16. PubMed ID: 12889277
[No Abstract] [Full Text] [Related]
14. Pharmaceuticals and medical devices: medical devices. Issue brief.
Health Policy Tracking Service, A Service of Thomson Reuters/West
Issue Brief Health Policy Track Serv; 2011 Jan; ():1-24. PubMed ID: 21374838
[No Abstract] [Full Text] [Related]
15. Pharmaceuticals and medical devices: medical devices.
Berry MD
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
[No Abstract] [Full Text] [Related]
16. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
17. Modernizing device regulation.
Kretzer RM; Foreman CL; Shuren J
N Engl J Med; 2010 Jul; 363(2):196-7; author reply 197. PubMed ID: 20653080
[No Abstract] [Full Text] [Related]
18. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
Mottes LM
Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761
[No Abstract] [Full Text] [Related]
19. The Bleeding Edge: Documenting Innovation and Injury in the Medical Device Industry.
Pendyal A; Ross JS
JAMA; 2019 Jul; 322(3):190-192. PubMed ID: 31310276
[No Abstract] [Full Text] [Related]
20. License to maim: federal pre-emption and the Medical Device Amendments of 1976.
Petrella ME
Health Matrix Clevel; 1996; 6(2):349-89. PubMed ID: 10178392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
